.svg)
Neurotechnology has evolved dramatically since the 1970s, which brought peripheral nerve stimulation and near-infrared spectroscopy, for example. Today, advances like optically pumped magnetometers, functional ultrasound, microelectrode arrays, and stentrodes revolutionised neural recording.
Mirroring Moore’s law, the number of neurons recorded simultaneously doubled every seven years from 1960 to 2010. These breakthroughs enabled speech decoding, motor function restoration, and tremor reduction. At e184, we aim to bring brain-machine interfaces (BMIs) into everyday life, transforming how we interact with technology.
Neurotechnology has evolved dramatically since the 1970s, which brought peripheral nerve stimulation and near-infrared spectroscopy, for example. Today, advances like optically pumped magnetometers, functional ultrasound, microelectrode arrays, and stentrodes revolutionised neural recording.
Mirroring Moore’s law, the number of neurons recorded simultaneously doubled every seven years from 1960 to 2010. These breakthroughs enabled speech decoding, motor function restoration, and tremor reduction. At e184, we aim to bring brain-machine interfaces (BMIs) into everyday life, transforming how we interact with technology.
Alejandro Aguilera Castrejon is the principal investigator at the Aguilera Castrejon Lab at the Howard Hughes Medical Institute Janelia Research Campus. His research focuses on mammalian embryogenesis, with a particular interest in gastrulation and the patterning of organs and tissues. Alejandro develops innovative platforms for growing natural and stem cell-derived mouse embryos outside the uterine environment to study both normal and disrupted development.
Alex is responsible for executing e184's vision by turning it into an actionable strategy and overseeing its day-to-day operations. He's an investment professional with experience that includes Draper X (a VC firm led by the legendary Tim Draper) and running his own investment banking advisory boutique.
Bijan Pesaran is the Robert A. Groff Professor of Research and Teaching in Neurosurgery II and Professor of Neuroscience and Bioengineering at the Perelman School of Medicine at the University of Pennsylvania. Bijan has received a Burroughs-Wellcome Career Award in the Biomedical Sciences, a Sloan Research Fellowship, a McKnight Scholar Award, and the National Science Foundation CAREER Award, among other awards. In 2013, he was a CV Starr Visiting Scholar at the Princeton Neuroscience Institute at Princeton University. Among others National Institutes of Health and National Science Foundation funded Bijan’s research.
Daniele serves as Professor in Quantum Technologies at the University of Glasgow, where he leads the Extreme-Light group and acts as Director of Research for the School of Physics and Astronomy. He also holds an adjunct professorship at the University of Arizona and is a Fellow of the Optical Society of America.
Among other things Daniele is a Royal Academy Chair in Emerging Technologies, Fellow of the Royal Society of Edinburgh and was awarded the Philip Leverhulme Prize in Physics in 2015.
Fernanda’s main focus at e184 is on assisted reproductive technologies (ART). Her background lies at the intersection of genetics, data, machine learning, and finance — a bit of everything.
-min.png)
Kirill Eves is a visionary serial entrepreneur and founder, building successful industry-shaping fintech companies for over 15 years. His portfolio includes Unlimit.com, one of the largest global payment infrastructures.
Marianna's role is to build high-performance teams that deliver breakthrough results with dedication and passion. She is a people management professional and executive coach with an international background (ex-PwC, ex-Embria) in multiple industries. TEDx talks about building teams.
Peter leads neurotech practice at e184. He was previously an investment manager at 7percent Ventures, a London-based deep tech fund. During his career, Peter invested across the aerospace, transportation, and agriculture sectors and the data stack.
Sofia focuses on neurotechnology research at e184. She is an undergraduate student in biomedical engineering with laboratory experience in synthetic chemistry, drug delivery systems, computational research, and published work on neurodevelopment and HIV.
Her passion for neurotech stems from her hands-on research experience and deep interest in bridging biotech and investment. She has seen firsthand how funding drives scientific breakthroughs, shaping the pace and direction of innovation.
Vasileios Christopoulos is an Assistant Professor in the Department of Biomedical Engineering at the University of Southern California (USC). He also holds positions as a Visiting Associate in the Division of Biology and Biological Engineering at the California Institute of Technology (Caltech) and as an Adjunct Clinical Assistant Professor of Neurological Surgery at the Keck School of Medicine at USC.Among other things, Vasileios has been named a Hellman Fellow, received awards from Shirley Ryan AbilityLab and National Institutes of Health.
Zana is responsible for legal affairs at e184. Having previously worked at Clifford Chance as an associate, he has extensive experience in domestic and cross-border acquisition finance, project finance, and capital markets transactions. He has also worked on numerous M&As and equity investments, with involvement in high-profile projects across sectors including technology, energy, pharmaceuticals, and FMCG.
